Company overview
Axion BioSystems develops live-cell analysis tools including multielectrode array (MEA) platforms, bioelectronic assays, and high-throughput imaging systems like Omni Pro 12 for real-time cell function monitoring. These technologies support drug discovery, disease research, and cell/gene therapy development without animal testing, used in biopharma and academia for applications in neurology, oncology, and neuroimmunology. Products enable noninvasive electrical/optical stimulation, AI-driven imaging, and automated cell counting.
Explore our live-cell analysis platforms is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include live-cell imaging, multielectrode array, mea platforms, drug discovery tools, cell analysis systems.
Structured facts
- Website
- https://www.axionbiosystems.com
- Markets served
- United States & Americas
- Keywords
- live-cell imaging, multielectrode array, mea platforms, drug discovery tools, cell analysis systems
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What live-cell analysis platforms does Axion BioSystems offer?
- Axion offers Maestro MEA platforms for electrical activity recording, Omni live-cell imaging systems with AI analysis for brightfield/fluorescence, and tools for optical/electrical stimulation in neural networks.
- What applications are supported by Axion's products?
- Products support drug discovery in neurology, oncology, neuroimmunology, cell/gene therapies, and real-time monitoring of cellular growth, death, excitability, and network connectivity.
- Are Axion BioSystems products suitable for high-throughput workflows?
- Yes, the Omni Pro 12 provides high-throughput live-cell imaging with integrated robotics, multiplate incubator compatibility, and automated imaging for enhanced efficiency in experiments.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
